Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AH Auxilium HealthCompany profile Auxilium Health makes bioaerogel biomaterials that block bacteria and aid tissue regeneration Auxilium Health makes bioaerogel biomaterials that block bacteria and aid tissue regeneration | $3.4M | Seed | Biotech, Healthtech | United States | Investors Undisclosed | |
| DT Draig TherapeuticsCompany profile Developing transformative, best-in-class neuropsychiatric therapies Developing transformative, best-in-class neuropsychiatric therapies | $65M | Series B |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| Biotech |
| United Kingdom |
| Investors |
| CD Building AI models to accelerate pre-clinical drug discovery | $400M | Series CSeries C+ | Biotech | United States | Investors |
| DF Drug FarmCompany profile Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases | $55M | Series DSeries C+ | Biotech | China | Investors |
| KA Kuehnle AgroSystemsCompany profile Develops sustainable microalgal ingredients using proprietary dark fermentation technology Develops sustainable microalgal ingredients using proprietary dark fermentation technology | Undisclosed | Series B | Biotech | United States | Investors |
| AT Allotera TherapeuticsCompany profile Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies | $35M | Series CSeries C+ | Biotech | United States | Investors |
| LC Leo Cancer CareCompany profile Designs cancer care systems around the body's natural upright position Designs cancer care systems around the body's natural upright position | $65M | Series DSeries C+ | Biotech, Healthtech | United States | Investors |
| RD Respiro DiagnosticsCompany profile Develops breath-based diagnostic platform for lung cancer and respiratory diseases Develops breath-based diagnostic platform for lung cancer and respiratory diseases | £1M | Pre-SeedPre-seed | Biotech, Healthtech | United Kingdom | Investors |
| A Develops new crop varieties from wild plants for sustainable agriculture | €5M | Seed | Biotech, Agritech | Netherlands | Investors |
| HT Healome TherapeuticsCompany profile Develops proprietary eye-drop matrix technology for ocular surface diseases Develops proprietary eye-drop matrix technology for ocular surface diseases | £2M | Seed | Biotech | United Kingdom | Investors |